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Résumé en
anglais
Glial cell line-derived neurotrophic factor (GDNF) has shown promise in the
treatment of neurodegenerative disorders of basal ganglia origin such us Parkinson's
disease (PD). In this study, we investigated the neurorestorative effect of controlled
GDNF delivery using biodegradable microspheres in an animal model with partial
dopaminergic lesion. Microspheres were loaded with N-glycosylated recombinant
GDNF and prepared using the Total Recirculation One-Machine System (TROMS).
GDNF-loaded microparticles were unilaterally injected into the rat striatum by
stereotaxic surgery two weeks after a unilateral partial 6-OHDA nigrostriatal lesion.
Animals were tested for amphetamine-induced rotational asymmetry at different
times and were sacrificed two months after microsphere implantation for
immunohistochemical analysis. The putative presence of serum IgG antibodies
against rat glycosylated GDNF was analyzed for addressing safety issues. The results
demonstrated that GDNF-loaded microspheres, improved the rotational behavior
induced by amphetamine of the GDNF-treated animals together with an increase in
the density of TH positive fibers at the striatal level. The developed GDNF-loaded
microparticles proved to be suitable to release biologically active GDNF over up to 5
weeks in vivo. Furthermore, none of the animals developed antibodies against GDNF
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